Psychiatric disorder co-morbidity and correlates in an ethnically diverse sample of obese patients with binge eating disorder in primary care settings
Introduction
Binge eating disorder (BED), a research category in the Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) [1], is characterized by recurrent binge eating without inappropriate compensatory weight-control behaviors. BED is a prevalent problem strongly associated with obesity and psychosocial impairment [2]. BED has distinctive psychopathology from other disordered eating groups [3], [4] that is significantly elevated relative to obese controls [5], [6]. BED has been added as a formal diagnosis in the current proposal for DSM-5 (www.dsm5.org) as critical reviews have concluded that sufficient evidence exists for BED to warrant its inclusion [7].
The study of diagnostic co-occurrence can contribute to developing models of etiology and has relevance for treatment formulation. Several studies have examined psychiatric co-morbidity in patients with varying definitions of BED using various approaches to recruitment (e.g., community, convenience, treatment-seeking at research clinics), assessment (e.g., self-report and interview methods), and comparison groups. We briefly note here the major findings from selected rigorous studies using diagnostic interviews. In the first controlled study of psychiatric co-morbidity in patients diagnosed with BED, Yanovski and colleagues [8] reported that 43 obese subjects with BED were significantly more likely to have co-occurring DSM-III-R-defined psychiatric disorders than 85 obese subjects without BED (60% versus 34%, respectively). Wilfley and colleagues [9], in a study of 162 patients with BED participating in a clinical trial, found that 77% of the patients met criteria for at least one additional DSM-III-R lifetime psychiatric disorder; mood, substance-use, and anxiety disorders were most common (61%, 33%, and 29%, respectively). Hudson and colleagues [2] reported that 79% of persons with BED met criteria for at least one additional DSM-IV lifetime psychiatric disorder in the National Comorbidity Replication Study; anxiety, mood, and substance use were most common (65%, 46%, and 23%, respectively). Javaras and colleagues [10], in a community-based study, reported elevated rates of most psychiatric disorders in persons with BED relative to those without BED. Grilo and colleagues [11] in a study of 404 consecutive patients with BED assessed at a research clinic reported that 74% met criteria for at least one additional DSM-IV lifetime psychiatric disorder and that 43% had at least one additional current disorder. Lifetime-wise, mood, anxiety, and substance use disorders were most common (54%, 37%, and 25%, respectively) at rates that echo those of the previous reports.
Although research has consistently reported elevated rates of psychiatric co-morbidity in obese BED groups relative to obese groups [10], less is known about the significance of psychiatric co-morbidity within BED (within group correlates). The Wilfley et al [9] DSM-III-R-based study, but not the Grilo et al [11] DSM-IV-based study, found that overall lifetime psychiatric co-morbidity was significantly more likely in men than women, although both studies reported that men were significantly more likely to have lifetime histories of substance use disorders. Grilo et al. [11] and Wilfley et al [9] both found that psychiatric co-morbidity was unrelated to body mass index or to binge-eating frequency; however, Wilfley et al [9] reported no association with eating-disorder psychopathology whereas Grilo et al [11] found significant associations between current psychiatric co-morbidity and higher eating-disorder psychopathology, as did a smaller study by Peterson et al [12] based on self-report measures. Thus, relatively little is known regarding the nature and significance of DSM-IV psychiatric co-morbidity within patient groups with BED. The literature consistently highlights the high rates of co-occurring psychiatric disorders in BED but is mixed regarding the relationship of co-morbid conditions to eating-disorder psychopathology. The mixed findings are perhaps due in part to limited power of some studies and varied recruitment and assessment methods.
The present study examined psychiatric co-morbidity in an ethnically diverse sample of obese patients with BED seeking treatment for obesity and binge eating in primary care, which is important for several reasons. First, the existing clinical literature is based on samples of treatment-seekers from specialist research clinics [9], [11], [12] and those findings may not generalize adequately to other clinical settings due to various “clinic biases” [13], [14], [15]. Second, the existing literature is based on samples comprised predominately of Caucasian participants and findings may not generalize to more diverse groups comprising different ethnic composition [16]. Epidemiological studies have found that African American and Hispanic groups have comparable rates of binge-eating as Caucasians [17], [18] but in sharp contrast to such prevalence data, African–American and Hispanic persons have been vastly under-represented in clinical studies of BED at research clinics [16]. Epidemiological studies have also found that minority groups with binge-eating problems have lower mental health utilization rates than Caucasians and receive most of their health care from generalist or primary care settings rather than from specialist settings [18]. Third, although BED appears to be common in primary care settings and associated with increased medical problems and service utilization [19], research has documented that general healthcare providers are unfamiliar with and often miss problems with BED [20] resulting in little available knowledge about this patient group.
Section snippets
Participants
Participants were a consecutive series of 142 patients who were respondents for a treatment study for obese persons who binge eat being performed in primary care settings in a large university-based medical center in an urban setting. Participants were required to be obese (body mass index (BMI) ≥ 30) and meet proposed DSM-5 criteria for BED. Unlike DSM-IV criteria for BED, which requires a minimum frequency of twice-weekly binge-eating, the DSM-5 stipulates a minimum frequency of once-weekly
Lifetime psychiatric co-morbidity: overall and by gender
Table 1 summarizes the frequency of lifetime psychiatric disorders overall and separately by gender and findings from chi-square analyses testing for gender differences in the distribution of other disorders. Overall, 67% of BED patients had at least one additional lifetime psychiatric disorder. Mood disorders (49%) were most common, with major depressive disorder being the most common specific disorder (44%). Anxiety disorders (41%) were also quite common, with PTSD being the most common
Discussion
This study assessed DSM-IV lifetime and current psychiatric disorder co-morbidity in ethnically diverse obese patients with BED seeking treatment in primary care. Much like findings reported from research and specialty clinics [11] patients with BED who present for treatment at primary care settings frequently have additional lifetime and current psychiatric disorders. Overall, 67% of BED patients had at least one additional lifetime psychiatric disorder and 37% had at least one current
References (41)
- et al.
The prevalence and correlates of eating disorders in the NCS replication
Biol Psychiatry
(2007) - et al.
Overvaluation of shape and weight in binge eating disorder, bulimia nervosa, and sub-threshold bulimia nervosa
Behav Res Ther
(2009) - et al.
Psychometric properties of the Beck Depression Inventory: 25 years of evaluation
Clin Psychol Rev
(1988) Diagnostic and statistical manual of mental disorders (4th ed., DSM-IV)
(1994)- et al.
Binge eating disorder and night eating syndrome: a comparative study of disordered eating
J Consult Clin Psychol
(2005) - et al.
Overvaluation of shape and weight in binge eating disorder and overweight controls: refinement of a diagnostic construct
J Abnorm Psychol
(2008) - et al.
Significance of overvaluation of shape/weight in binge-eating disorder: comparative study with overweight and bulimia nervosa
Obesity
(2010) - et al.
The validity and clinical utility of binge eating disorder
Int J Eat Disord
(2009) - et al.
Association of binge eating disorder and psychiatric comorbidity in obese subjects
Am J Psychiatry
(1993) - et al.
Comorbid psychopathology in binge eating disorder: relation to eating disorder severity at baseline and following treatment
J Consult Clin Psychol
(2000)
Co-occurrence of binge eating disorder with psychiatric and medical disorders
J Clin Psychiatry
DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder
Int J Eat Disord
Subtypes of binge eating disorder based on psychiatric history
Int J Eat Disord
Ethnicity and sampling bias in binge eating disorder
Int J Eat Disord
A comparison of black and white women with binge eating disorder
Am J Psychiatry
Bias in binge eating disorder: how representative are recruited clinic samples?
J Consult Clin Psychol
Racial/ethnic differences in adults in randomized clinical trials of binge eating disorder
J Consult Clin Psychol
Prevalence and correlates of eating disorders in Latinos in the United States
Int J Eat Disord
Comparative prevalence, correlates of impairment, and service utilization for eating disorders across US ethnic groups: implications for reducing ethnic disparities in health care access for eating disorders
Int J Eat Disord
Health problems, impairment and illnesses associated with bulimia nervosa and binge eating disorder among primary care and obstetric gynaecology patients
Psychol Med
Cited by (57)
Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder
2021, European NeuropsychopharmacologyCitation Excerpt :BED is often co-morbid with obesity and obesity-related physical symptoms (Citrome, 2019; Kessler et al., 2013; Papelbaum et al., 2019). In addition to impairing physical health, BED is associated with mood and anxiety disorders, bipolar disorder, self-harm, and addiction disorders (Grilo et al., 2013; Peters et al., 2019; Schulz and Laessle, 2010; Swanson et al., 2011). Current treatments for BED include cognitive behavioural therapy (CBT) and behavioural weight loss therapy (BWLT) (Wilson et al., 2010).
Sex and gender differences in compulsive overeating
2019, Compulsive Eating Behavior and Food Addiction: Emerging Pathological ConstructsBinge Eating Disorder and Bipolar Spectrum disorders in obesity: Psychopathological and eating behaviors differences according to comorbidities
2017, Journal of Affective DisordersEating disorders among African-Americans
2023, Changing the Stigma of Mental Health Among African Americans: Moving From Denial to Acceptance
This study was supported by the National Institutes of Health (R01 DK073542). Dr. Grilo was also supported by National Institutes of Health grant K24 DK070052 and Dr. Barnes by National Institutes of Health grant K23 DK092279.